Pharsight

SUPERNUS PHARMACEUTICALS patents facing oppositions

Top patents of SUPERNUS PHARMACEUTICALS facing oppositions at the European Patent Office (EPO).

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP2552210B1 20 Dec, 2017 Formulations of mazindol NA 1
EP1589951B1 09 Aug, 2017 Use of a mixture of two or more enteric materials to regulate drug release via membrane or matrix for systemic therapeutics Jan, 2024 1